|
PABPC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61089996897346E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.366000E-04 |
| Normal-vs-Stage2 |
1.562450E-04 |
| Normal-vs-Stage3 |
1.937840E-03 |
| Normal-vs-Stage4 |
1.095430E-03 |
| Stage1-vs-Stage2 |
5.576900E-03 |
| Stage1-vs-Stage3 |
7.706000E-02 |
| Stage1-vs-Stage4 |
3.804100E-03 |
| Stage2-vs-Stage3 |
9.437800E-01 |
| Stage2-vs-Stage4 |
2.199900E-02 |
| Stage3-vs-Stage4 |
7.257300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.36749999604768E-08 |
| Normal-vs-AfricanAmerican |
4.10360000000498E-05 |
| Normal-vs-Asian |
8.438300E-02 |
| Caucasian-vs-AfricanAmerican |
8.143600E-01 |
| Caucasian-vs-Asian |
2.589000E-01 |
| AfricanAmerican-vs-Asian |
2.470200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.38019999662964E-08 |
| Normal-vs-Female |
7.89249999799679E-08 |
| Male-vs-Female |
6.750400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.98959999999837E-05 |
| Normal-vs-Extreme_Weight |
1.396960E-04 |
| Normal-vs-Obese |
1.60039999996808E-06 |
| Normal-vs-Extreme_Obese |
1.065640E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.977700E-02 |
| Normal_Weight-vs-Obese |
9.378800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.182400E-01 |
| Extreme_Weight-vs-Obese |
3.996100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.771200E-01 |
| Obese-vs-Extreme_Obese |
3.325600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.640800E-04 |
| Normal-vs-Age(41-60Yrs) |
2.59260000134987E-08 |
| Normal-vs-Age(61-80Yrs) |
4.62390000000035E-06 |
| Normal-vs-Age(81-100Yrs) |
1.319170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.090420E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.099300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.099800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.426200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.277600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.260600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.72030000034474E-07 |
| Normal-VS-Type2 PRCC |
8.393200E-04 |
| Normal-VS-KIRP CIMP |
6.4799999999976E-05 |
| Normal-VS-Unclassified PRCC |
2.41619999999942E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.214000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.971400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.380000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.68190025742854E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
7.580100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.77070000018898E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.630400E-04 |
| Normal-vs-N1 |
4.29960000000174E-05 |
| Normal-vs-N2 |
1.793770E-02 |
| N0-vs-N1 |
2.357000E-03 |
| N0-vs-N2 |
4.14469999998612E-06 |
| N1-vs-N2 |
3.320400E-01 |
|
|
